Beijing
China
14
2026-05-28
The entities that hold a legal rights for patent applications filed by inventor Wang Lai:
Lai Wang from Beijing, CN has applied for patents for these inventions. The list has both pending applications and granted patents:
SIGNAL RECEIVING METHOD, SIGNAL SENDING METHOD, SIGNAL RECEIVING APPARATUS, AND SIGNAL SENDING APPARATUS
#2 | 2024-04-11Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)- 2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof
#3 | 2023-11-16USE OF A COMBINATION COMPRISING A BTK INHIBITOR FOR TREATING CANCERS
#4 | 2023-08-03COMPOSITIONS COMPRISING (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-CARBOXAMIDE
#5 | 2023-03-23METHODS OF TREATING DLBCL USING BTK INHIBITORS AND COMBINATIONS THEREOF
#6 | 2022-10-27Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof
#7 | 2022-09-08Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof
#8 | 2021-09-09Treatment of B cell cancers using a combination comprising Btk inhibitors
#9 | 2021-07-29Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer
#10 | 2021-07-08MAINTENANCE THERAPY OF A PARP INHIBITOR IN TREATING GASTRIC CANCER
#11 | 2021-05-20Immunotherapy for hepatocellular carcinoma
#12 | 2020-05-21TREATMENT OF CANCERS USING A COMBINATION COMPRISING PARP INHIBITORS, TEMOZOLOMIDE AND/OR RADIATION THERAPY
#13 | 2020-03-05Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer
#14 | 2020-01-30Treatment cancers using a combination comprising PARP inhibitors
2626708 ⎘